DARA RATLIFF: Open Payments
NPI 1265162010 · RICHLANDS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 21 payments from 16 companies in 2025. Trend: 2023 $316 · 2024 $147 · 2025 $528
Food & beverage: $435Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $109 |
| Astellas Pharma US Inc | 3 | $73 |
| Daiichi Sankyo Inc. | 3 | $63 |
| PharmaEssentia USA Corporation | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: IMBRUVICA, DATROWAY, Padcev, BESREMI, KEYTRUDA, KISQALI, VERZENIO, PYRUKYND.
Industry payments across VA — which companies pay providers there.
